BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[Biomarin Pharma has what investors call a 'pipeline of significance']]>http://www.bloggingstocks.com/2008/01/11/biomarin-pharma-has-what-investors-call-a-pipeline-of-significa/http://www.bloggingstocks.com/2008/01/11/biomarin-pharma-has-what-investors-call-a-pipeline-of-significa/http://www.bloggingstocks.com/2008/01/11/biomarin-pharma-has-what-investors-call-a-pipeline-of-significa/#commentsFiled under: ,

Uncertain economic times, it goes without saying, create uphill conditions for most stocks. But that does not mean one should not search for promising opportunities, and one that fits the bill, for high-risk investors, is Biomarin Pharmaceutical.

Biomarin Pharmaceutical Inc. (Nasdaq: BMRN) develops and commercializes drugs for rare and chronic diseases.

Analysts like the fact that two of its drugs qualify for FDA orphan drug status, which grants exclusive marketing rights for seven years.

Biomarin's Aldurazyme, the sole therapy for mucopolysaccharidosis I (MPS I), obtained orphan drug status in the U.S. for seven years and in Europe for 10 years. Also, the company's Naglazyme is approved in the U.S. and Europe to treat MPS VI (Maroteaux-Lamy syndrome), another rare, genetic disease. The Reuters FY 2007/FY 2008 EPS consensus estimates for BMRN are -$0.15 to $0.49.

Continue reading Biomarin Pharma has what investors call a 'pipeline of significance'

Biomarin Pharma has what investors call a 'pipeline of significance' originally appeared on BloggingStocks on Fri, 11 Jan 2008 18:09:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>11108Biomarin PharmaceuticalBMRNdrugsFDAMPS IMPS VIorphan drugsPharmaceutical sectorU.S. Food and Drug AdministrationFri, 11 Jan 2008 18:09:00 EST